Skip to main content

Portal Hypertension; Definition, Etiology and Management!

 PORTAL HYPERTENSION

Definition:

"Portal Hyperension is present when the hepatic venous pressure gradient exceeds 10mmHg and risk of variceal bleeding increases beyond a gradient of 12mmHg."



Classification: According to The Site of Action:

1. Pre-Hepatic, Pre-Sinusoidal:

    Caused by;

  •          Portal vein thrombosis due to sepsis
  •          Abdominal trauma including surgery.


2. Intra-hepatic pre-sinusoidal:

   Caused by; 

  •         Schistosomiasis
  •         Congenital hepatic fibrosis
  •         Drugs
  •         Sarcoidosis


3. Sinusoidal:

    Caused by; 

  •         Cirrhosis
  •         Polycystic liver disease
  •        Nodular regenerative hyperplasia
  •        Metastatic malignant disease


4. Intrahepatic Post-sinusoidal:

    Caused by; 

  •       Veno-occlusive disease


5. Post-hepatic post-sinusoidal:

  Caused by;

  •       Budd-Chiari syndrome


Etiology:

  1. Cirrhosis
  2. Schistosomiasis
  3. Portal vein thrombosis
  4. Drugs
  5. Fibrosis


Clinical Features:

  1. Variceal bleeding
  2. Congestive gastropathy
  3. Renal failure
  4. Iron deficiency anemia
  5. Hepatic encephalopathy
  6. Splenomegaly


Pathophysiology:

  • Increased portal vascular resistance leads to gradual reduction in flow of portal blood to liver and simultaneously to the development of collateral vessels, allowing portal blood to bypass liver and enter systemic circulation directly.
  • Poly systemic shunting occurs, particularly in the GIT and especially in the distal esophagus, stomach and rectum, in the anterior abdominal wall and in the renal, lumbar, ovarian and testicular vasculature.



Investigations:

  1. Portal venous Pressure is measured: by using a balloon catheter inserted using a trans jugular route.
  2. Endoscopy
  3. Ultrasonography
  4. CT scan
  5. MRI


Management of Bleeding:

1. IV Fluids: To replace the extracellular volume.

2. Vasopressor: To reduce the portal pressure, acute bleeding and risk of early bleeding.

3. Prophylactic Antibiotics (Cephalosporins IV): To reduce incidence of spontaneous bacterial peritonitis.

4. Emergency Endoscopy: To confirm variceal rather than ulcer bleeding.

5. PPI: To prevent peptic ulcer.

6. Variceal Band Ligation: To stop bleeding.

7. Phosphate Enema/ Lactulose: To prevent hepatic encephalopathy.


Management of Acute Bleeding From Esophageal Varices:

  1. If suspected variceal hemorrhage.
  2. Start IV Terlipressin (Vasopressor) and Antibiotics prophylaxis.
  3. Urgent Upper GI Endoscopy:
  4. If Varices present, go for, Endoscopic Therapy. (If no varices present; stop Terlipressin.)
  5. Is there hemostasis. If yes; continue Terlipressin to 72hr. Introduce Beta-blocker as secondary prophylaxis. Enter the patient to endoscopic banding program to obliterate varices. (If no Hemostats; Further endoscopic therapy or Ballon Tamporate and Emergency Trans jugular Intrahepatic Portosystemic Stent Shunt (TIPSS)).



Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more

Myocardial Infarction- Etiology, Pathogenesis, Clinical Diagnosis and Management!

MYOCARDIAL INFARCTION Definition: Myocardial Infarction is defined as " a diseased condition which is caused by reduced blood flow to the coronary artery due to atherosclerosis and occlusion of artery by embolus or thrombus." Myocardial Infarction (or Heart attack) is the irreversible damage of myocardial tissue due to prolonged ischemia or hypoxia. Universally accepted definition of MI:  Evidence of myocardial necrosis in consistent with the myocardial ischemia, in which case any of the following meets the diagnosis of Myocardial Infarction. Evidence rises and/or fall of cardiac biomarkers (preferably troponin). ECG changes indicative of new ischemia (new ST-T changes or new left bundle branch block) Development of pathological Q waves. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. Etiology: Tobacco smoking Diabetes Mellitus Age Hypertension Obesity Gender Stress Drug abuse Alcohol consumption Family history of ischemic heart dise...
Post a Comment
Read more